250 related articles for article (PubMed ID: 32793731)
1. Successful treatment of secondary macrophage activation syndrome with emapalumab in a patient with newly diagnosed adult-onset Still's disease: case report and review of the literature.
Gabr JB; Liu E; Mian S; Pillittere J; Bonilla E; Banki K; Perl A
Ann Transl Med; 2020 Jul; 8(14):887. PubMed ID: 32793731
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2021; 12():750114. PubMed ID: 34691064
[TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics of the Anti-Interferon-Gamma Monoclonal Antibody Emapalumab: An Updated Analysis.
Brossard P; Laveille C
Rheumatol Ther; 2024 Jun; 11(3):869-880. PubMed ID: 38662147
[TBL] [Abstract][Full Text] [Related]
4. Macrophage Activation Syndrome (MAS): A Case Report and Narrative Review.
Dilibe A; Ugoala OS; Evbayekha EO; Khalilullah MZ; Adabale OK; Poyser TA; Oriaifo OF; Olori UI; Aiwuyo HO
Cureus; 2023 Mar; 15(3):e35670. PubMed ID: 37012949
[TBL] [Abstract][Full Text] [Related]
5. Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease.
Ruscitti P; Ursini F; Berardicurti O; Masedu F; Bozzalla Cassione E; Naldi S; Di Cola I; Di Muzio C; De Stefano L; Di Nino E; Navarini L; Vomero M; Bugatti S; Valenti M; Mariani E; Iagnocco A; Montecucco C; Giacomelli R; Cipriani P
Rheumatology (Oxford); 2022 Dec; 62(1):321-329. PubMed ID: 35438139
[TBL] [Abstract][Full Text] [Related]
6. A Novel Therapy for a Rare Condition: Continuous Anakinra Infusion for a Patient With Macrophage Activation Syndrome.
Gullickson M; Nichols L; Scheibe M
Cureus; 2023 Aug; 15(8):e42968. PubMed ID: 37667692
[TBL] [Abstract][Full Text] [Related]
7. Atypical Adult-Onset Still's Disease Presenting With Seizures and Myocarditis Complicated by Macrophage Activation Syndrome.
Le AN; Gudushauri N; Tan IJ; Bhat R; Khan R
Cureus; 2024 Jan; 16(1):e52635. PubMed ID: 38374832
[TBL] [Abstract][Full Text] [Related]
8. A Challenging Case of Adult-Onset Still's Disease Complicated by Macrophage Activation Syndrome With Multiorgan Failure.
Mohamed A; K A Yasin A; Mohamed A; Elamin N; Mustafa S; Fadul A; Syed G; Al-Tikrity M
Cureus; 2023 Aug; 15(8):e43128. PubMed ID: 37692615
[TBL] [Abstract][Full Text] [Related]
9. Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature.
Lenert A; Yao Q
Semin Arthritis Rheum; 2016 Jun; 45(6):711-6. PubMed ID: 26672682
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of emapalumab in macrophage activation syndrome.
De Benedetti F; Grom AA; Brogan PA; Bracaglia C; Pardeo M; Marucci G; Eleftheriou D; Papadopoulou C; Schulert GS; Quartier P; Antón J; Laveille C; Frederiksen R; Asnaghi V; Ballabio M; Jacqmin P; de Min C
Ann Rheum Dis; 2023 Jun; 82(6):857-865. PubMed ID: 37001971
[TBL] [Abstract][Full Text] [Related]
11. Macrophage activation syndrome associated with adult-onset Still's disease: a multicenter retrospective analysis.
Wang R; Li T; Ye S; Tan W; Zhao C; Li Y; de Bao C; Fu Q
Clin Rheumatol; 2020 Aug; 39(8):2379-2386. PubMed ID: 32130578
[TBL] [Abstract][Full Text] [Related]
12. Macrophage Activation Syndrome Versus Hemophagocytic Lymphohistiocytosis: A Diagnostic Dilemma in a Patient With Still's Disease and Epstein-Barr Virus Viremia.
Gomez R; Maakaron J; Baiocchi R
J Hematol; 2019 Jun; 8(2):68-70. PubMed ID: 32300447
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in patients with adult-onset Still's disease under tocilizumab treatment: A single-center observational study.
Yamabe T; Ohmura SI; Uehara K; Naniwa T
Mod Rheumatol; 2022 Jan; 32(1):169-176. PubMed ID: 33719871
[TBL] [Abstract][Full Text] [Related]
14. An atypical presentation of adult-onset Still's disease complicated by pulmonary hypertension and macrophage activation syndrome treated with immunosuppression: a case-based review of the literature.
Mehta MV; Manson DK; Horn EM; Haythe J
Pulm Circ; 2016 Mar; 6(1):136-42. PubMed ID: 27162622
[TBL] [Abstract][Full Text] [Related]
15. A Diagnostic Dilemma: Adult-Onset Still's Disease With Secondary Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome?
Parkash O; Anand AS; Shayuk M
J Med Cases; 2023 May; 14(5):179-183. PubMed ID: 37303972
[TBL] [Abstract][Full Text] [Related]
16. A Case of Macrophage Activation Syndrome During the Treatment of Adult-onset Still's Disease With Tocilizumab.
Lee JH; Ha YJ; Kang EH; Chang SH; Lee YJ; Sup ; Sup
J Rheum Dis; 2022 Apr; 29(2):123-128. PubMed ID: 37475901
[TBL] [Abstract][Full Text] [Related]
17. Case report: Emapalumab for active disease control prior to hematopoietic stem cell transplantation in refractory systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
Chellapandian D; Milojevic D
Front Pediatr; 2023; 11():1123104. PubMed ID: 36891226
[TBL] [Abstract][Full Text] [Related]
18. The Pathogenic Role of Interferons in the Hyperinflammatory Response on Adult-Onset Still's Disease and Macrophage Activation Syndrome: Paving the Way towards New Therapeutic Targets.
Di Cola I; Ruscitti P; Giacomelli R; Cipriani P
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33802085
[TBL] [Abstract][Full Text] [Related]
19. Biallelic mutations in the CFHR genes underlying atypical hemolytic uremic syndrome in a patient with catastrophic adult-onset Still's disease and recurrent macrophage activation syndrome: A case report.
Dillemans L; Bekhuis Y; Betrains A; Yu K; van Hemelen M; Pörtner N; De Somer L; Matthys P; Breckpot J; Tousseyn T; Peetermans M; Proost P; Wouters C; Vanderschueren S
Clin Immunol; 2023 Dec; 257():109815. PubMed ID: 37898413
[TBL] [Abstract][Full Text] [Related]
20. Are the 2016 EULAR/ACR/PRINTO classification criteria for macrophage activation syndrome applicable to patients with adult-onset Still's disease?
Tada Y; Inokuchi S; Maruyama A; Suematsu R; Sakai M; Sadanaga Y; Ono N; Arinobu Y; Koarada S
Rheumatol Int; 2019 Jan; 39(1):97-104. PubMed ID: 30051293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
